Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆
-
Published:2021-10
Issue:5
Volume:6
Page:100250
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Gaspar N.ORCID,
Campbell-Hewson Q.,
Gallego Melcon S.,
Locatelli F.,
Venkatramani R.,
Hecker-Nolting S.,
Gambart M.,
Bautista F.,
Thebaud E.,
Aerts I.,
Morland B.,
Rossig C.,
Canete Nieto A.,
Longhi A.,
Lervat C.,
Entz-Werle N.,
Strauss S.J.,
Marec-Berard P.,
Okpara C.E.,
He C.,
Dutta L.,
Casanova M.
Funder
Eisai Inc
Merck Sharp and Dohme
Subject
Cancer Research,Oncology
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献